The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric
Read More...
Read the complete post at https://blog.aids.gov/2015/11/fda-approves-new-treatment-for-hiv.html
Posted
Nov 10 2015, 06:00 AM
by
blog.aids.gov — HIV Policy & Programs. Research. New Media.